A Closer Look at 7 Analyst Recommendations For Catalyst Pharmaceuticals
A Closer Look at 7 Analyst Recommendations For Catalyst Pharmaceuticals
分析师建议聚焦catalyst pharmaceuticals公司
Catalyst Pharmaceuticals (NASDAQ:CPRX) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在过去的三个月中，Catalyst Pharmaceuticals (NASDAQ:CPRX) 已经被7位分析师进行了分析，展示出了从看好到看淡的不同观点。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格总结了分析师们最近的评级，揭示了过去30天内情绪的变化并将其与前几个月进行了比较。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $28.43, along with a high estimate of $34.00 and a low estimate of $23.00. Marking an increase of 7.98%, the current average surpasses the previous average price target of $26.33.
分析师提供了更深层次的见解，他们建立了12个月的目标价值，显示平均目标价值为28.43美元，最高价值为34.00美元，最低价值为23.00美元。当前的平均目标价值增加了7.98％，超过了以前的平均目标价值26.33美元。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细剖析
The perception of Catalyst Pharmaceuticals by financial...
通过最近的分析...
登录免费看全文
登录/注册